Belimumab 10 mg/kg vs placebo
Participants with one or more serious adverse events · people with active systemic lupus erythematosus (but not active nephritis or active central nervous system involvement)
Belimumab 10 mg/kg showed no clear difference in participants with one or more serious adverse events compared with placebo (low certainty).
1 finding from 1 review
- RR 0.87 [0.68, 1.11]5 studies · 2890 participantsLow